These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8601525

  • 1. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S, Nakano H, Tsuneyoshi M.
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [Abstract] [Full Text] [Related]

  • 2. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K, Demopoulos RI.
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [Abstract] [Full Text] [Related]

  • 3. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D, Babić D, Forko JI, Martinac I.
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K.
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [Abstract] [Full Text] [Related]

  • 5. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
    Oshiro Y, Fukuda T, Tsuneyoshi M.
    Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM, Komorowski RA, Wilson SD, Demeure MJ, Zhu YR.
    Cancer; 1999 Oct 15; 86(8):1583-9. PubMed ID: 10526289
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K.
    Acta Obstet Gynecol Scand; 2004 Nov 15; 83(11):1085-8. PubMed ID: 15488127
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Cancer; 1996 Jan 01; 77(1):164-71. PubMed ID: 8630925
    [Abstract] [Full Text] [Related]

  • 12. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D.
    Lab Invest; 1994 Jan 01; 70(1):125-9. PubMed ID: 7905542
    [Abstract] [Full Text] [Related]

  • 13. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA, Topuz S, Tuzlali S, Bengisu E, Berkman S.
    Gynecol Oncol; 2005 Oct 01; 99(1):36-42. PubMed ID: 15992918
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B, Sökmensüer C.
    Hepatogastroenterology; 2003 Dec 01; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [Abstract] [Full Text] [Related]

  • 15. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN, Finkelstein SD, Jones MW.
    Mod Pathol; 1999 Nov 01; 12(11):1001-9. PubMed ID: 10574596
    [Abstract] [Full Text] [Related]

  • 16. Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas.
    Mittal K, Joutovsky A.
    Gynecol Oncol; 2007 Feb 01; 104(2):362-5. PubMed ID: 17011615
    [Abstract] [Full Text] [Related]

  • 17. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S.
    Anticancer Res; 1994 Feb 01; 14(3B):1305-12. PubMed ID: 7915093
    [Abstract] [Full Text] [Related]

  • 18. Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord.
    Iwata K, Nakagawa H, Hashizume Y.
    Noshuyo Byori; 1996 Apr 01; 13(1):73-8. PubMed ID: 8916130
    [Abstract] [Full Text] [Related]

  • 19. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 01; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 20. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J, Wu L, Xiao H, Li N, Wang H, Cheng C, Bai R, Zhao Y, Zheng H.
    Int J Gynecol Pathol; 2010 Jan 01; 29(1):55-62. PubMed ID: 19952936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.